<DOC>
	<DOCNO>NCT01449539</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy hyperbaric oxygen therapy ( HBOT ) therapeutic option mobilize stem cell autologous stem cell transplant .</brief_summary>
	<brief_title>Study Hyperbaric Oxygen Therapy Addition Standard Growth Factor Support Hematopoietic Progenitor/Stem Cell Mobilization</brief_title>
	<detailed_description>Subjects receive HBOT daily 10 day conjunction standard growth factor treatment regimens stem cell mobilization . The role HBOT stem cell mobilization well role oxidative stress evaluate .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Patients consider autologous stem cell transplant part routine care fail least one prior attempt stem cell mobilization currently available standard regimen use growth factor . Patients use Mozobil® medically justify possible insurance financial reason Patients schedule begin standard growth factor treatment Neupogen® part routine care . Patients bone marrow evaluation perform within one month prior enrollment part routine clinical care IRB # 02815 . Patients chest xray CT Chest within 60 day prior enrollment . ECOG performance status ≤ 3 perform within 60 day prior enrollment determined history . Patients least 18 year age time registration . Patient must sign IRBapproved informed consent understand investigational nature study . Clinically significant hepatic dysfunction note direct bilirubin AST &gt; 3 time upper normal limit clinically significant concurrent hepatitis within 60 day prior enrollment . History New York Heart Association ( NYHA ) Class III Class IV heart failure Recent ( &lt; 6 month ) myocardial infarction , unstable angina , difficult control congestive heart failure , uncontrolled hypertension , difficult control cardiac arrhythmias medical history . Untreated pneumothorax medical history . Uncontrolled seizure disorder medical history Uncontrolled insulin dependent diabetes ( verified routine labs medical record ) History severe claustrophobia Severe COPD ( FEV1 &lt; 50 % predict pulmonary function test ) perform within 60 day prior enrollment Untreated ear barotraumas medical history Pregnancy currently breastfeed ( female childbearing potential must agree use adequate contraception study ) . A urine pregnancy test perform prior initiate HBOT . Patients currently receive Bleomycin , Cisplatin , Disulfiram , Doxorubicin , Sulfamylon . Any condition PI determines may jeopardize safety subject course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Hyperbaric oxygen</keyword>
	<keyword>mobilize</keyword>
	<keyword>stem cell</keyword>
	<keyword>growth factor</keyword>
</DOC>